anetumab,bevacizumab
roche,bayer
['anetumab', 'beva', 'bevacizumab']
#asco22: dr. eugenia girda ( ) &amp; colleagues present a randomized ph2 study of bevacizumab &amp; weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant or refractory o#variancancer... . 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.